Apogee Therapeutics soars on report Abbvie nearing $11 bln buyout deal

Apogee Therapeutics

22/06/2026 10:55

** Shares of drug developer Apogee Therapeutics APGE.O jump 54.4% to $139.5 premarket 
** Abbvie ABBV.N nearing deal to buy APGE for $10.9 bln in cash, Financial Times reported on Friday
** Deal would value the drug developer at roughly 60% premium to Thursday's close - report
     ** As of last close, APGE market cap was at $6.8 bln - LSEG data
** APGE secured $1.3 bln financing deal from Blackstone for experimental eczema drug
** As of last close, APGE stock was up 19.7% YTD

 (Reporting by Utkarsh Hathi in Bengaluru)
 ((utkarshtushar.hathi@thomsonreuters.com))